1. < Home

Irritable Bowel Syndrome

Prebiotics and Probiotics for Gastrointestinal Disorders

Rau S, Gregg A, Yaceczko S, Limketkai B. Prebiotics and Probiotics for Gastrointestinal Disorders. Nutrients. 2024 Mar 9;16(6):778. doi: 10.3390/nu16060778. PMID: 38542689.

By sjmartinez • March 28, 2024
Patient-Reported Outcomes in Disorders of Gut-Brain Interaction

Tack J, Carbone F, Chang L, Lacy BE. Patient-Reported Outcomes in Disorders of Gut-Brain Interaction. Gastroenterology. 2024 Apr;166(4):572-587.e1. doi: 10.1053/j.gastro.2023.11.307. Epub 2024 Feb 1. PMID:[...]

By sjmartinez • March 25, 2024
Patient reported outcomes in Disorders of Gut-Brain Interaction

Tack J, Carbone F, Chang L, Lacy BE. Patient reported outcomes in Disorders of Gut-Brain Interaction. Gastroenterology. 2024 Feb 1:S0016-5085(24)00124-0. doi: 10.1053/j.gastro.2023.11.307. Epub ahead of[...]

By sjmartinez • February 4, 2024
Neural correlates of perceived and relative resilience in male and female patients with irritable bowel syndrome

Kilpatrick LA, Gupta A, Tillisch K, Labus JS, Naliboff BD, Mayer EA, Chang L. Neural correlates of perceived and relative resilience in male and female[...]

By sjmartinez • November 30, 2023
Maximizing Training and Mentorship in Sex as a Biological Variable Research Across Different Brain-Body Disorders

Chang L, Gupta A, Naliboff BD, Labus J, Kilpatrick LA, Mayer EA. Maximizing Training and Mentorship in Sex as a Biological Variable Research Across Different[...]

By sjmartinez • August 17, 2023
The Association Between a Mediterranean Diet and Symptoms of Irritable Bowel Syndrome

Chen E, Mahurkar-Joshi S, Liu C, Jaffe N, Labus J, Dong T, Gupta A, Patel S, Mayer EA, Chang L. The Association Between a Mediterranean[...]

By sjmartinez • July 31, 2023
Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo-controlled trials in adults with severe constipation

Cash BD, Sharma A, Walker A, Laitman AP, Chang L. Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post[...]

By sjmartinez • June 19, 2023
Randomized controlled pilot study assessing fructose tolerance during fructose reintroduction in non-constipated irritable bowel syndrome patients successfully treated with a low FODMAP diet

Cuff C, Lin LD, Mahurkar-Joshi S, Jacobs JP, Lagishetty V, Jaffe N, Smith J, Dong T, Sohn J, Chang L. Randomized controlled pilot study assessing[...]

By sjmartinez • April 14, 2023
Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points

Lacy BE, Chang L, Rao SSC, Heimanson Z, Sayuk GS. Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis[...]

By sjmartinez • March 16, 2023
Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE)

Chang L, Cash BD, Lembo A, Kunkel DC, English BA, Lindstrom B, Gu G, Skare S, Gilder K, Turner S, Cataldi F, Lipkis D, Jan[...]

By sjmartinez • February 7, 2023